HCRT and Huntington disease: Although the metabolic regulator orexin is reduced in the hypothalamus of clinical HD and in the rAAV model, the number of the orexin immunopositive cells are in fact increased but atrophied in BACHD mice [21], [22], [23], [24], [25].